Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma
全面的 CRISPR-Cas9 筛查可确定多发性骨髓瘤药物反应的遗传决定因素
期刊:Blood Advances
影响因子:7.4
doi:10.1182/bloodadvances.2020003541
Stephan R Bohl, Laura K Schmalbrock, Imke Bauhuf, Tatjana Meyer, Anna Dolnik, Martin Szyska, Tamara J Blätte, Sarah Knödler, Linda Röhner, Denise Miller, Miriam Kull, Christian Langer, Hartmut Döhner, Anthony Letai, Frederik Damm, Dirk Heckl, Lars Bullinger, Jan Krönke